Usefulness therapy for hepatocellular carcinoma located at hepatic dome: value of artificial pleural effusion

Hotta, Naoki; Fukuzawa, Yoshitaka; Okumura, Akihiko; Ishikawa, Tetsuya; Kakumu*, Shinichi
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS85
Academic Journal
An abstract of the article "Usefulness Therapy for Hepatocellular Carcinoma Located at Hepatic Dome: Value of Artificial Pleural Effusion," by Naoki Hotta, Yoshitaka Fukuzawa, Akihiko Okumura, Tetsuya Ishikawa and Shinichi Kakumu is presented.


Related Articles

  • Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. Minami, Yasunori; Kudo, Masatoshi; Kawasaki, Toshihiko; Chung, Hobyung; Ogawa, Chikara; Inoue, Tatsuo; Sakaguchi, Yasuhiro; Sakamoto, Hiroki; Shiozaki, Hitoshi // Journal of Gastroenterology;2003, Vol. 38 Issue 11, p1066 

    Background Methods. Between May 2001 and June 2002, 24 patients with 28 HCC nodules located directly below the diaphragm were enrolled in this study. The patient population included 17 men and 7 women (age range, 51–87 years; mean age, 66.5 years). The maximum diameter of the HCC nodules...

  • Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. Uehara, Takahide; Hirooka, Masashi; Ishida, Kiyotaka; Hiraoka, Atsushi; Kumagi, Teru; Kisaka, Yoshiyasu; Hiasa, Yoichi; Onji, Morikazu // Journal of Gastroenterology;Apr2007, Vol. 42 Issue 4, p306 

    Ultrasound-guided procedures are sometimes of limited use because the tumor is located under the diaphragm or near the surface of the liver. We investigated the safety and efficacy of radiofrequency ablation (RFA) with artificial pleural effusion and/or artificial ascites. Between January 2002...

  • Precautions in caudate lobe resection: Report of 11 cases. Zeng-Qing Wen; Yi-Qun Yan; Jia-Mei Yang; Meng-Chao Wu; Koniaris, Leonidas G. // World Journal of Gastroenterology;5/7/2008, Vol. 14 Issue 17, p2767 

    AIM: To find the precautions against the safety in caudate lobe resection. METHODS: The clinical data obtained from 11 cases of primary liver cancer in caudate lobe who received hepatectomy successfully were retrospectively analyzed. Four safe procedures were used in resection of primary liver...

  • High-dose-rate interstitial brachytherapy for liver metastases: first study from India. Sharma, DAYA Nand; Thulkar, Sanjay; Sharma, Seema; Gandhi, Ajeet Kumar; Haresh, Kunhi Parambath; Gupta, Subhash; Rath, Goura Kisor; Julka, Pramod Kumar // Journal of Contemporary Brachytherapy;2013, Vol. 5 Issue 2, p70 

    Purpose: To study the safety and efficacy of high-dose-rate interstitial brachytherapy (HDRIBT) in patients with liver metastases (LM). Material and methods: Between 2009 and 2011,10 patients with 12 metastatic lesions in the liver were enrolled in this prospective trial. All patients had either...

  • Risk Factors Influencing Postoperative Outcomes of Major Hepatic Resection of Hepatocellular Carcinoma for Patients with Underlying Liver Diseases. Tian Yang; Jin Zhang; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu; Wei-Feng Yu // World Journal of Surgery;Sep2011, Vol. 35 Issue 9, p2073 

    Background: Major hepatic resection of more than three segments in patients with hepatocellular carcinoma (HCC) is a high-risk operation, especially in patients with co-existing underlying liver diseases. The present study evaluated risk factors for postoperative morbidity and mortality after...

  • Radiofrequency ablation for hepatocellular carcinoma: use of low vs maximal radiofrequency power. Macatula, T. C.; Lin, C.-C.; Lin, C.-J.; Chen, W.-T.; Lin, S.-M. // British Journal of Radiology;Jun2012, Vol. 85 Issue 1014, pe102 

    Objectives: To investigate whether radiofrequency (RF) ablation with low power (LP) or maximal power (MP) for hepatocellular carcinoma (HCC) can achieve optimal ablation and fewer adverse effects. Methods: RF ablation was performed with MP in 101 patients (129 tumours) and with LP in 46 patients...

  • Acute Presentation of Hepatoblastoma in a 9 Years Old Girl. Balaji, M. D.; Shivaprakash, N. C.; Akkammal Sathyabama, K. // Indian Journal of Trauma & Emergency Pediatrics;Jul-Dec2015, Vol. 7 Issue 3/4, p109 

    Hepatoblastoma is the most common primary malignancy of the liver encountered in children. Primary tumors of the liver account for approximately 1% of malignancies in children. 50-60% of hepatic tumors in children are malignant, with >65% of these malignancies being hepatoblastomas....

  • Pleural fluid in hospitalized pediatric patients. Alkrinawi, S.; Chernick, V. // Clinical Pediatrics;Jan1996, Vol. 35 Issue 1, p5 

    Looks at a review of charts on children hospitalized in Canada with pleural effusion established by radiographic study to the chest between 1987-1993. Findings; Statistics; Age group; Conditions associated with pleural effusion.

  • Diagnosis and management of malignant pleural effusions.  // American Family Physician;11/1/1995, Vol. 52 Issue 6, p1886 

    Reports on an article published by Fenton and Richardson in the July 1995 issue of the `American Journal of Surgery' on the diagnosis and management of malignant pleural effusions.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics